DR. DANIEL J WALLACE (M.D.) – Rheumatology Physician, NPI 1982608717
Preparing for Medicare enrollment?
Use our CMS-855 prep checklist: which form applies (855I, 855O, or 855A), readiness score, NPPES field map, and Section 12 documents. Reassignment uses CMS-855I Section 4F—not the discontinued CMS-855R form.
Open Medicare 855 Prep tool →Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
Loading map...
Provider Addresses for DR. DANIEL J WALLACE (M.D.)
PO BOX 18736
BEVERLY HILLS, CA 902094736
Phone: (310) 652-0920
Fax: (310) 360-4812
Type: Mailing
Wilshire Boulevard, Beverly Hills, Los Angeles County, California, 90048, United States
STE 350
BEVERLY HILLS, CA 902112703
Phone: (310) 652-0920
Fax: (310) 652-2482
Type: Location
8750 WILSHIRE BLVD STE 210
BEVERLY HILLS, CA 902112703
Phone: (310) 652-0920
Fax: (310) 652-2482
Type: Location
8730 Alden Dr
Los Angeles, CA 90048
Phone: (310) 423-3870
Fax: (310) 423-0429
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 260 Open Payments records for all available years, with a total value of $107,593.
Total Amount is formed as General ($107,593) + Research ($0) + Ownership ($0) = $107,593.
Last reported payment date: 2024-12-23 • Largest payer in this snapshot: AstraZeneca Pharmaceuticals LP ($49,299).
Total Amount
$107,593
General + Research + Ownership
Payments
260
Total payment records
General Amount
$107,593
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-23
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| AstraZeneca Pharmaceuticals LP | $49,299 |
| Servier BioInnovation | $19,905 |
| GlaxoSmithKline, LLC. | $17,672 |
| Aurinia Pharma U.S., Inc. | $7,364 |
| Amgen Inc. | $5,239 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
No Medicare enrollment or revalidation data available for this provider in our database.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,200 | 14 | $0 |
| J3262 | Injection, tocilizumab, 1 mg | 38,772 | 16 | $0 |
| J1306 | Injection, inclisiran, 1 mg | 12,632 | 29 | $0 |
| J0897 | Injection, denosumab, 1 mg | 6,540 | 81 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,081 | 12 | $0 |
Insurance plans in this area (ZIP 90209)
Loading plans...
Provider's Procedures
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.